Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 15571546)

Published in J Am Geriatr Soc on December 01, 2004

Authors

Molly M Shores1, Victoria M Moceri, David A Gruenewald, Kayla I Brodkin, Alvin M Matsumoto, Daniel R Kivlahan

Author Affiliations

1: VA Puget Sound Health Care System, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington 98108, USA. molly.shores@med.va.gov

Articles citing this

Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 1.74

The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci (2012) 1.13

The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. J Obes (2010) 1.11

Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab (2011) 0.99

Testosterone and cardiovascular disease in men. Asian J Androl (2012) 0.94

Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol (2013) 0.93

Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study. J Family Community Med (2013) 0.87

Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging? Clin J Am Soc Nephrol (2010) 0.86

The Anxiolytic and Antidepressant-like Effects of Testosterone and Estrogen in Gonadectomized Male Rats. Biol Psychiatry (2015) 0.84

The concept of multiple hormonal dysregulation. Acta Biomed (2010) 0.83

Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes (2014) 0.78

Androgens and male aging: Current evidence of safety and efficacy. Asian J Androl (2010) 0.77

Testosterone is not associated with mortality in older African-American males. Aging Male (2010) 0.75

Articles by these authors

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15

Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res (2007) 5.97

AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res (2007) 5.60

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58

Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clin Cancer Res (2011) 4.65

Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet (2003) 3.78

Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med (2003) 3.45

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab (2004) 3.02

Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res (2011) 2.81

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab (2004) 2.73

Persistent intraprostatic androgen concentrations after medical castration in healthy men. J Clin Endocrinol Metab (2006) 2.57

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab (2004) 2.39

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab (2004) 2.35

Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab (2012) 2.29

Low serum testosterone and mortality in male veterans. Arch Intern Med (2006) 2.28

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend (2002) 1.97

Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment. Arch Intern Med (2004) 1.94

Alcohol screening scores and medication nonadherence. Ann Intern Med (2008) 1.94

Implementation of evidence-based alcohol screening in the Veterans Health Administration. Am J Manag Care (2006) 1.83

The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction (2008) 1.82

Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups. J Gen Intern Med (2008) 1.77

Screening for post-traumatic stress disorder in female Veteran's Affairs patients: validation of the PTSD checklist. Gen Hosp Psychiatry (2002) 1.65

Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care (2011) 1.60

Telephone self-monitoring among alcohol use disorder patients in early recovery: a randomized study of feasibility and measurement reactivity. Drug Alcohol Depend (2005) 1.58

The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab (2007) 1.53

Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy. Am J Public Health (2011) 1.51

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care (2004) 1.47

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46

Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment. J Androl (2007) 1.45

Implementation of ICU palliative care guidelines and procedures: a quality improvement initiative following an investigation of alleged euthanasia. Chest (2009) 1.44

Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial. Fertil Steril (2012) 1.44

Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend (2009) 1.42

Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study. Addiction (2006) 1.41

Serum testosterone and estradiol in sudden infant death. J Pediatr (2005) 1.40

The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab (2008) 1.37

Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv (2010) 1.36

Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv (2012) 1.33

Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry (2004) 1.30

Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol (Oxf) (2007) 1.30

Increased documented brief alcohol interventions with a performance measure and electronic decision support. Med Care (2012) 1.28

Associations of housing status with substance abuse treatment and service use outcomes among veterans. Psychiatr Serv (2010) 1.25

The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend (2004) 1.24

Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc (2003) 1.24

Testosterone administration suppresses adiponectin levels in men. J Androl (2004) 1.24

Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology (2005) 1.24

Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol (2004) 1.22

Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am J Physiol Endocrinol Metab (2005) 1.21

Cortisol levels and measures of body composition in middle-aged and older men. Clin Endocrinol (Oxf) (2007) 1.20

Serum testosterone assays--accuracy matters. J Clin Endocrinol Metab (2004) 1.19

Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab (2005) 1.19

A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry (2009) 1.18

AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers. Alcohol Clin Exp Res (2013) 1.17

Readiness to change in primary care patients who screened positive for alcohol misuse. Ann Fam Med (2006) 1.17

Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure. J Subst Abuse Treat (2008) 1.15

Brief approaches to alcohol screening: practical alternatives for primary care. J Gen Intern Med (2009) 1.15

Quality concerns with routine alcohol screening in VA clinical settings. J Gen Intern Med (2010) 1.15

Targeted androgen pathway suppression in localized prostate cancer: a pilot study. J Clin Oncol (2013) 1.14

Developing and validating process measures of health care quality: an application to alcohol use disorder treatment. Med Care (2009) 1.11

Recognition and management of alcohol misuse in OEF/OIF and other veterans in the VA: a cross-sectional study. Drug Alcohol Depend (2010) 1.11

Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc (2002) 1.09

Using alcohol screening results and treatment history to assess the severity of at-risk drinking in Veterans Affairs primary care patients. Alcohol Clin Exp Res (2004) 1.08

Brief motivational feedback improves post-incarceration treatment contact among veterans with substance use disorders. Drug Alcohol Depend (2003) 1.07

Measuring performance of brief alcohol counseling in medical settings:a review of the options and lessons from the Veterans Affairs (VA) health care system. Subst Abus (2007) 1.07

Examining quality issues in alcohol misuse screening. Subst Abus (2007) 1.07

Alcohol screening scores and risk of hospitalizations for GI conditions in men. Alcohol Clin Exp Res (2007) 1.07

Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab (2006) 1.05

Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry (2005) 1.04

Cost methodology of COMBINE. J Stud Alcohol Suppl (2005) 1.04

Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial. J Clin Endocrinol Metab (2010) 1.04

Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. J Androl (2004) 1.00

Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med (2011) 0.99

Suicidal ideation in multiple sclerosis. Arch Phys Med Rehabil (2006) 0.98

Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology (2003) 0.98

Blue rubber bleb nevus syndrome in a patient with ataxia and dementia. J Geriatr Psychiatry Neurol (2002) 0.98

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab (2004) 0.97

Factorial designs in clinical trials: options for combination treatment studies. J Stud Alcohol Suppl (2005) 0.97

Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment. Med Care (2006) 0.97

Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc (2002) 0.96

Mindful awareness in body-oriented therapy for female veterans with post-traumatic stress disorder taking prescription analgesics for chronic pain: a feasibility study. Altern Ther Health Med (2007) 0.96

Concurrent monitoring of psychological distress and satisfaction measures as predictors of addiction treatment retention. J Subst Abuse Treat (2007) 0.95

Assessing nondrinking outcomes in combined pharmacotherapy and psychotherapy clinical trials for the treatment of alcohol dependence. J Stud Alcohol Suppl (2005) 0.95

Use of an electronic clinical reminder for brief alcohol counseling is associated with resolution of unhealthy alcohol use at follow-up screening. J Gen Intern Med (2010) 0.94

When quality indicators undermine quality: bias in a quality indicator of follow-up for alcohol misuse. Psychiatr Serv (2013) 0.93

Screening for substance abuse and psychiatric disorders among women patients in a VA Health Care System. Psychiatr Serv (2003) 0.93

Evidence-based national initiatives to address tobacco use as a public health priority in the Veterans Health Administration. Mil Med (2009) 0.92

Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab (2014) 0.92

Exercise and quality of life among people with multiple sclerosis: looking beyond physical functioning to mental health and participation in life. Arch Phys Med Rehabil (2009) 0.91

Measuring economic outcomes of alcohol treatment using the Economic Form 90. J Stud Alcohol Drugs (2007) 0.91

The association between alcohol screening scores and health status in male veterans. J Addict Med (2010) 0.91

Posttraumatic stress disorder screening status is associated with increased VA medical and surgical utilization in women. J Gen Intern Med (2006) 0.90

Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen. Contraception (2007) 0.90

Hepatitis C tested prevalence and comorbidities among veterans in the US Northwest. J Clin Gastroenterol (2004) 0.90

Design and analysis of trials of combination therapies. J Stud Alcohol Suppl (2005) 0.90